![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 29, 26699-26707, July 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Division of Experimental Therapeutics, Ontario Cancer
Institute, Princess Margaret Hospital, University Health Network and
the Department of Medical Biophysics, University of Toronto,
Toronto, Ontario M5G 2M9, Canada
Previous studies in our laboratory and
others identified placental transforming growth factor-
A Novel p53 Transcriptional Repressor Element (p53TRE) and
the Asymmetrical Contribution of Two p53 Binding Sites Modulate the
Response of the Placental Transforming Growth Factor-
Promoter to
p53*
(PTGF-
)
as an important downstream mediator of DNA damage signaling and a
transcriptional target of p53. Here we show that accumulation of
PTGF-
mRNA in response to p53 overexpression is delayed relative
to p21WAF1, whereas the promoters of these
genes respond to p53 with similar kinetics. Mutational analyses of two
p53 binding sites within the PTGF-
promoter revealed that site p53-1
(+29 bp) is responsible for as much as 80% of the transcriptional
response to p53. This is consistent with electrophoretic mobility shift
assays showing that site p53-1 binds p53 with a much higher affinity
than site p53-2 (
850 bp). We also describe for the first time a novel
21-bp element (
222 to
242 bp) that acts to down-regulate the
PTGF-
promoter response to p53. Termed the p53 transcriptional
repressor element (p53TRE), this sequence was shown to suppress p53
transactivation in a position- and promoter-independent fashion and to
associate with a 28-kDa protein expressed in several tumor cell lines.
A p53 suppressor element and asymmetric p53 binding sites may
participate determining the activation thresholds of p53-responsive
promoters in a cell- and context-specific manner.
*
This work was supported by grants from the Canadian
Institutes for Health Research, the Canadian Breast Cancer Foundation, and an Ontario Graduate Scholarship in Science and Technology fellowship (to J. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Medical
Biophysics, University of Toronto, Ontario Cancer Institute, Princess
Margaret Hospital, 610 University Ave., Rm. 10-721, Toronto, Ontario
M5G 2M9, Canada. Tel.: 416-946-2981; Fax: 416-946-2984; E-mail:
hklamut@uhnres.utoronto.ca.
This article has been cited by other articles:
![]() |
X. Luo, Q. He, Y. Huang, and M. S. Sheikh Cloning and Characterization of a p53 and DNA Damage Down-regulated Gene PIQ that Codes for a Novel Calmodulin-Binding IQ Motif Protein and Is Up-regulated in Gastrointestinal Cancers Cancer Res., December 1, 2005; 65(23): 10725 - 10733. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pati, B. R. Haddad, A. Haegele, H. Thompson, F. S. Kittrell, A. Shepard, C. Montagna, N. Zhang, G. Ge, S. K. Otta, et al. Hormone-Induced Chromosomal Instability in p53-Null Mammary Epithelium Cancer Res., August 15, 2004; 64(16): 5608 - 5616. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Lee, Y. Yang, S. J. Lee, K.-Y. Kim, T. H. Koo, S. M. Shin, K. S. Song, Y. H. Lee, Y.-J. Kim, J. J. Lee, et al. Macrophage Inhibitory Cytokine-1 Induces the Invasiveness of Gastric Cancer Cells by Up-Regulating the Urokinase-type Plasminogen Activator System Cancer Res., August 1, 2003; 63(15): 4648 - 4655. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Newman, M. Sakaue, J. S. Koo, K.-S. Kim, S. J. Baek, T. Eling, and A. M. Jetten Differential Regulation of Nonsteroidal Anti-Inflammatory Drug-Activated Gene in Normal Human Tracheobronchial Epithelial and Lung Carcinoma Cells by Retinoids Mol. Pharmacol., March 1, 2003; 63(3): 557 - 564. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |